Literature DB >> 22572238

Liver regenerative medicine: advances and challenges.

Dimitry A Chistiakov1.   

Abstract

Liver transplantation is the standard care for many end-stage liver diseases. However, donor organs are scarce and some people succumb to liver failure before a donor is found. Liver regenerative medicine is a special interdisciplinary field of medicine focused on the development of new therapies incorporating stem cells, gene therapy and engineered tissues in order to repair or replace the damaged organ. In this review we consider the emerging progress achieved in the hepatic regenerative medicine within the last decade. The review starts with the characterization of liver organogenesis, fetal and adult stem/progenitor cells. Then, applications of primary hepatocytes, embryonic and adult (mesenchymal, hematopoietic and induced pluripotent) stem cells in cell therapy of liver diseases are considered. Current advances and challenges in producing mature hepatocytes from stem/progenitor cells are discussed. A section about hepatic tissue engineering includes consideration of synthetic and natural biomaterials in engineering scaffolds, strategies and achievements in the development of 3D bioactive matrices and 3D hepatocyte cultures, liver microengineering, generating bioartificial liver and prospects for fabrication of the bioengineered liver.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2012        PMID: 22572238     DOI: 10.1159/000335697

Source DB:  PubMed          Journal:  Cells Tissues Organs        ISSN: 1422-6405            Impact factor:   2.481


  12 in total

Review 1.  Hepatic stellate cells in liver development, regeneration, and cancer.

Authors:  Chunyue Yin; Kimberley J Evason; Kinji Asahina; Didier Y R Stainier
Journal:  J Clin Invest       Date:  2013-05-01       Impact factor: 14.808

2.  Self-assembled liver organoids recapitulate hepatobiliary organogenesis in vitro.

Authors:  Dipen Vyas; Pedro M Baptista; Matthew Brovold; Emma Moran; Brandon Gaston; Chris Booth; Michael Samuel; Anthony Atala; Shay Soker
Journal:  Hepatology       Date:  2018-01-02       Impact factor: 17.425

Review 3.  Cellular therapy for liver disease.

Authors:  Robert C Huebert; Jorge Rakela
Journal:  Mayo Clin Proc       Date:  2014-03       Impact factor: 7.616

Review 4.  Naturally-Derived Biomaterials for Tissue Engineering Applications.

Authors:  Matthew Brovold; Joana I Almeida; Iris Pla-Palacín; Pilar Sainz-Arnal; Natalia Sánchez-Romero; Jesus J Rivas; Helen Almeida; Pablo Royo Dachary; Trinidad Serrano-Aulló; Shay Soker; Pedro M Baptista
Journal:  Adv Exp Med Biol       Date:  2018       Impact factor: 2.622

Review 5.  Therapeutic hepatocyte transplant for inherited metabolic disorders: functional considerations, recent outcomes and future prospects.

Authors:  Kara R Vogel; Andrew A Kennedy; Luke A Whitehouse; K Michael Gibson
Journal:  J Inherit Metab Dis       Date:  2013-10-02       Impact factor: 4.982

6.  Murine Sca1(+)Lin(-) bone marrow contains an endodermal precursor population that differentiates into hepatocytes.

Authors:  Keunhee Oh; Suh Youn Shon; Myung Won Seo; Hak Mo Lee; Ju-Eun Oh; Eun Young Choi; Dong-Sup Lee; Kyong Soo Park
Journal:  Exp Mol Med       Date:  2015-10-02       Impact factor: 8.718

7.  Role of Hepatic-Specific Transcription Factors and Polycomb Repressive Complex 2 during Induction of Fibroblasts to Hepatic Fate.

Authors:  Shima Rastegar-Pouyani; Niusha Khazaei; Ping Wee; Abdulshakour Mohammadnia; Moein Yaqubi
Journal:  PLoS One       Date:  2016-11-30       Impact factor: 3.240

8.  Bone marrow-derived monocyte infusion improves hepatic fibrosis by decreasing osteopontin, TGF-β1, IL-13 and oxidative stress.

Authors:  Veruska Cintia Alexandrino de Souza; Thiago Almeida Pereira; Valéria Wanderley Teixeira; Helotonio Carvalho; Maria Carolina Accioly Brelaz de Castro; Carolline Guimarães D'assunção; Andréia Ferreira de Barros; Camila Lima Carvalho; Virgínia Maria Barros de Lorena; Vláudia Maria Assis Costa; Álvaro Aguiar Coelho Teixeira; Regina Celia Bressan Queiroz Figueiredo; Sheilla Andrade de Oliveira
Journal:  World J Gastroenterol       Date:  2017-07-28       Impact factor: 5.742

Review 9.  Telocytes in regenerative medicine.

Authors:  Yihua Bei; Fei Wang; Changqing Yang; Junjie Xiao
Journal:  J Cell Mol Med       Date:  2015-06-08       Impact factor: 5.310

10.  Hepatic differentiation of mouse bone marrow‑derived mesenchymal stem cells using a novel 3D culture system.

Authors:  Qiong Wu; Jing Tang; Yi Li; Li Li; Yujia Wang; Ji Bao; Hong Bu
Journal:  Mol Med Rep       Date:  2017-10-19       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.